Menu
Back to Equity and Access
02/18/26

False-negative screening and diagnostic mammograms in the National Mammography Database From 2010 to 2022.

Oluyemi, Eniola T; Grimm, Lars J; Goldman, Lenka; Lee, Michelle; Pittman, Sarah M; Rosen, Eric; Zuley, Margarita L; Lee, Cindy S. AJR Am J Roentgenol.

Collection Topics
Big Three Conditions Epidemiology Tests, Screening, and Laboratory Processes
Share

Most recent

Frequency, Type, and Degree of Potential Harm of Adverse Safety Events among Pediatric Emergency Medical Services Encounters.

Cicero, Baird, Brown, et al., Prehosp Emerg Care.
09/11/26 Cognition and Decision Making Epidemiology

Primary care signals and diagnostic pathways before incident heart failure: a systematic scoping review.

Jerjes, El-Osta, Jhass, et al., J Prim Care Community Health.
09/09/26 Big Three Conditions Culture, Work System, and Implementation Epidemiology

A business case for diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America (SHEA) Diagnostic Stewardship Special Interest Group.

Turbett, Daragiati, T. Chu, et al., Antimicrob Steward Healthc Epidemiol.
09/01/26 Business Case for Excellence Tests, Screening, and Laboratory Processes

Summary

False-negative (FN) mammograms can delay breast cancer diagnoses to impact clinical outcomes. This large retrospective study examines FN rates in screening and diagnostic mammograms from the National Mammography Database, identifying links between FN rates and patient or facility characteristics. The findings highlight the need to investigate these associations further to improve quality assurance and reduce delayed breast cancer diagnoses.

Read the paper
Oluyemi ET, Grimm LJ, Goldman L, et al. False-negative screening and diagnostic mammograms in the National Mammography Database From 2010 to 2022. AJR Am J Roentgenol. 2026;226(2):e2533636.